FDA Action Alert: Vericel and Provention Bio

Ahead of the July Fourth holiday, the U.S. Food and Drug Administration (FDA) has two PDUFA dates on the calendar. Here’s a look.

Vericel’s NexoBrid for Debridement for Burns

Vericel Corporation, based in Cambridge, Mass., has a target action date of June 29, 2021, for its Biologics License Application (BLA) for NexoBrid for eschar removal (debridement) in adults with deep partial-thickness and/or full-thickness thermal burns.